Alaunos Therapeutics | ZIOP - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Amgen USD 5.87B 1.02B 2026-03
AstraZeneca USD 12.86B 251M 2026-06
Baxter International USD 1.14B 251M 2026-06
Biogen USD 2.12B 307M 2026-06
Bioline Rx USD 382K 39K 2026-03
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Celltrion KRW 39.29B 7.7B 2026-03
Corcept Therapeutics USD 252.09M 90.07M 2026-06
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Curis USD 1.14M 8.86M 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 19.61B 2.49B 2026-06
Gilead Sciences USD 6.8B 1.29B 2026-06
GlaxoSmithKline GBP 6.51B 757M 2026-06
Incyte USD 1.57B 400.89M 2026-06
Intrexon USD -297K 167K 2024-06
Ionis Pharmaceuticals USD 265M 22M 2026-06
J&J USD 18.55B 1.31B 2026-06
Kangmei Pharma CNY 238.34M 31.95M 2026-03
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Medical Developments International AUD 7.35M 7.37M 2025-06
Merck USD 12.09B 1.24B 2026-03
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Novartis USD 11.24B 1.18B 2026-06
Organigram Holdings CAD 16.41M 6.91M 2026-03
Pfizer USD -248M 11.29B 2026-06
Pharma Mar EUR 44.87M 5.63M 2026-06
PTC Therapeutics USD 232.94M 84.56M 2026-03
Qiagen NV USD 340.39M 30.78M 2026-06
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Sartorius EUR 433.1M 18.6M 2026-06
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
TG Therapeutics USD 199.14M 27.73M 2026-06
Tilray USD 57.47M 10.16M 2025-06
Verastem USD 15.62M 977K 2026-03
Zealand Pharma A/S 34M 34.92M 2026-03
Zz Pientze Pharmaceu CNY 1.16B 860.2M 2026-03